Evangelia Emmanouilidou, PhD, studied chemistry at the University of Athens and obtained an MSc degree in Biochemistry from the University of Bristol, UK. She then received her PhD from the University of Athens. Her graduate work focused on the development of novel experimental setups for the diagnosis and monitoring of human diseases. Since 2004 she has been working at the Center for Basic Research at the Biomedical Research Foundation of the Academy of Athens (BRFAA), Greece, first as a postdoctoral fellow and later as a senior research scientist. The major focus of Dr. Emmanouilidou's work is mechanisms of protein production and degradation in a healthy brain and during neurodegeneration. She recently discovered molecules that play a key role in the process of alpha-synuclein production using pre-clinical in vitro and in vivo models of Parkinson's disease (PD).  Dr. Emmanouilidou recently became an assistant professor of biochemistry in the Department of Chemistry, University of Athens.